Tumor-Resident Streptococcus pneumoniae Promotes Malignant Progression and Pazopanib Resistance in Clear Cell Renal

Jinpeng Wang1,2, Yunfeng Nan1,2, Qing Liu2,3

  • 1Department of Urology, The Second Affiliated Hospital of Harbin Medical University, Harbin, China.

Cancer Research
|February 11, 2026
PubMed

Insights

Streptococcus pneumoniae in tumors drives pazopanib resistance in clear cell renal cell carcinoma (ccRCC) by altering lipid metabolism. This bacterium may serve as a biomarker for predicting patient response to this tyrosine kinase inhibitor.

Area of Science:

  • Oncology
  • Microbiology
  • Metabolic Research

Background:

  • Drug resistance to tyrosine kinase inhibitors (TKIs) limits survival in clear cell renal cell carcinoma (ccRCC).
  • Intratumoral bacteria have been implicated in cancer progression and treatment response.

Purpose of the Study:

  • To investigate the role of intratumoral microbiota in pazopanib resistance in ccRCC.
  • To identify specific bacteria associated with treatment resistance and elucidate their mechanisms of action.

Main Methods:

  • Microbiome screening of ccRCC patient samples treated with pazopanib.
  • Analysis of lipid metabolism reprogramming and molecular pathways in ccRCC cells.
  • Investigation of bacterial interactions with host cell proteins and metabolites.

Main Results:

  • Streptococcus pneumoniae (S. pneumoniae) was identified as the dominant intratumoral bacterium in pazopanib-resistant ccRCC.
  • S. pneumoniae depletes manganese (Mn2+), suppresses S-nitrosylation of TRIM28, and promotes lipid deposition via SP1/SLC27A1 axis.
  • This reprogramming facilitates malignant progression and pazopanib resistance.

Conclusions:

  • Tumor-resident S. pneumoniae contributes to pazopanib resistance in ccRCC by manipulating host lipid metabolism.
  • S. pneumoniae represents a potential predictive biomarker for pazopanib response in ccRCC patients.

Related Concept Videos

Tumor Progression02:07

Tumor Progression

Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
7.5K
The Eukaryotic Promoter Region02:40

The Eukaryotic Promoter Region

The eukaryotic promoter region is a segment of DNA located upstream of a gene. It contains an RNA polymerase binding site, a transcription start site, and several cis-regulatory sequences.  The proximal promoter region is located in the vicinity of the gene and has cis-regulatory sequences and the core promoter. The core promoter is the binding site for RNA polymerase and is usually located between -35 and +35 nucleotides from the transcription start site. The distal promoter regions are...
19.0K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
929
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

The pathophysiology of pneumonia involves the following steps:
3.1K
Cancer Stem Cells and Tumor Maintenance02:40

Cancer Stem Cells and Tumor Maintenance

Early diagnosis and treatment can often cure cancer. However, even with treatment, residual cells called cancer stem cells (CSC) might remain, often causing tumor recurrence. These cancer stem cells possess the potential for self-renewal and multi-lineage differentiation and are often responsible for the therapeutic resistance displayed in most cancers.
Cancer stem cells are thought to originate from tissue-specific normal stem cells or progenitor cells. The normal stem cells usually reside in...
6.0K
Noncompartmental Analysis: Mean Residence Time01:05

Noncompartmental Analysis: Mean Residence Time

According to statistical moment theory, mean residence time (MRT) is an important measure in pharmacokinetics. MRT can be defined as the expected mean of a probability density function distribution. It provides valuable insights into drug disposition in the body.
After the administration of a drug through intravenous bolus injection, the drug molecules are distributed throughout the body and remain there for varying periods. The MRT represents the average time these drug molecules stay in the...
619